Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa study.
Ma H, Lim TH, Leerapun A, Weltman M, Jia J, Lim YS, Tangkijvanich P, Sukeepaisarnjaroen W, Ji Y, Le Bert N, Li D, Zhang Y, Hamatake R, Tan N, Li C, Strasser SI, Ding H, Yoon JH, Stace NH, Ahmed T, Anderson DE, Yan L, Bertoletti A, Zhu Q, Yuen MF.
Ma H, et al.
JHEP Rep. 2021 Sep 8;3(6):100361. doi: 10.1016/j.jhepr.2021.100361. eCollection 2021 Dec.
JHEP Rep. 2021.
PMID: 34661089
Free PMC article.